Aisling Capital Management LP Long-Term Concentrated

Location: New York, NY

CIK: 0001766721 · Show all filings

Period: Q3 2023 (← Previous) (Next →)

Filing Date: Nov 13, 2023

Total Value: $243M (100.0% shares, 0.0% debt)

Holdings (17)

BBIO BridgeBio Pharma Inc. (BBIO) 65.9%

Value $160M Shares 6,068,125 Est. Cost $40.43 Unrealized -29.8%

— Verona Pharma plc (VRNA) 7.5%

Value $18.18M Shares 1,115,352 Est. Cost $7.38 Unrealized —

SNDX Syndax Pharmaceuticals, Inc. (SNDX) 6.1%

Value $14.88M Shares 1,025,000 Est. Cost $10.24 Unrealized +84.7%

BMEA Biomea Fusion Inc (BMEA) 4.5%

Value $10.99M Shares 798,757 Est. Cost $17.65 Unrealized +2.1%

CMPS Compass Pathways Plc (CMPS) 2.9%

Value $7.137M Shares 964,500 Est. Cost $7.40 Unrealized —

GLUE Monte Rosa Therapeutics Inc (GLUE) 2.9%

Value $7.052M Shares 1,472,331 Est. Cost $20.37 Unrealized -68.4%

— Reneo Pharmaceuticals Inc (RPHM) 2.8%

Value $6.743M Shares 886,075 Est. Cost $9.33 Unrealized —

NUVB Nuvation Bio Inc. (NUVB) 1.4%

Value $3.405M Shares 2,541,009 Est. Cost $11.18 Unrealized -85.1%

ACRS Aclaris Theraputics Inc (ACRS) 1.2%

Value $2.976M Shares 434,455 Est. Cost $10.31 Unrealized -17.1%

— Spruce Biosciences, Inc. (SPRB) 1.1%

Value $2.724M Shares 1,205,511 Est. Cost $24.31 Unrealized —

— Poseida Therapeutics Inc. (PSTX) 1.0%

Value $2.483M Shares 1,043,267 Est. Cost $8.87 Unrealized —

— Elevation Oncology Inc (ELEV) 0.8%

Value $1.878M Shares 2,834,910 Est. Cost $13.57 Unrealized —

— Avrobio, Inc. (AVRO) 0.6%

Value $1.555M Shares 1,009,779 Est. Cost $16.72 Unrealized —

MRKR Marker Therapeutics, Inc. (MRKR) 0.6%

Value $1.427M Shares 314,286 Est. Cost $1.74 Unrealized +221.5%

SYRE Aeglea Biotherapeutics Inc (AGLE) 0.3%

Value $829K Shares 67,645 Est. Cost $13.22 Unrealized 0.0%

— Viracta Therapeutics Inc (VIRX) 0.1%

Value $300K Shares 288,571 Est. Cost $11.34 Unrealized —

— Atreca Inc. (BCEL) 0.0%

Value $101K Shares 387,653 Est. Cost $18.84 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
BBIO	BridgeBio Pharma Inc. (BBIO)	6,068,125	$160M	65.9%	$40.43	-29.8%	COM	10806X102
—	Verona Pharma plc (VRNA)	1,115,352	$18.18M	7.5%	$7.38	—	SPONSORED ADS	925050106
SNDX	Syndax Pharmaceuticals, Inc. (SNDX)	1,025,000	$14.88M	6.1%	$10.24	+84.7%	COM	87164F105
BMEA	Biomea Fusion Inc (BMEA)	798,757	$10.99M	4.5%	$17.65	+2.1%	COM	09077A106
CMPS	Compass Pathways Plc (CMPS)	964,500	$7.137M	2.9%	$7.40	—	SPONSORED ADS	20451W101
GLUE	Monte Rosa Therapeutics Inc (GLUE)	1,472,331	$7.052M	2.9%	$20.37	-68.4%	COM	61225M102
—	Reneo Pharmaceuticals Inc (RPHM)	886,075	$6.743M	2.8%	$9.33	—	COM	75974E103
NUVB	Nuvation Bio Inc. (NUVB)	2,541,009	$3.405M	1.4%	$11.18	-85.1%	COM CL A	67080N101
ACRS	Aclaris Theraputics Inc (ACRS)	434,455	$2.976M	1.2%	$10.31	-17.1%	COM	00461U105
—	Spruce Biosciences, Inc. (SPRB)	1,205,511	$2.724M	1.1%	$24.31	—	COM	85209E109
—	Poseida Therapeutics Inc. (PSTX)	1,043,267	$2.483M	1.0%	$8.87	—	COM	73730P108
—	Elevation Oncology Inc (ELEV)	2,834,910	$1.878M	0.8%	$13.57	—	COM	28623U101
—	Avrobio, Inc. (AVRO)	1,009,779	$1.555M	0.6%	$16.72	—	COM	05455M100
MRKR	Marker Therapeutics, Inc. (MRKR)	314,286	$1.427M	0.6%	$1.74	+221.5%	COM	57055L206
SYRE	Aeglea Biotherapeutics Inc (AGLE)	67,645	$829K	0.3%	$13.22	0.0%	COM NEW	00773J202
—	Viracta Therapeutics Inc (VIRX)	288,571	$300K	0.1%	$11.34	—	COM	92765F108
—	Atreca Inc. (BCEL)	387,653	$101K	0.0%	$18.84	—	CL A COM	04965G109